Copay Accumulator Programs Allowed In 2023 Private Insurance Market In Proposed Rule

Commercial payer programs to undercut manufacturer cost sharing assistance for drugs may continue next year under proposed rule released by the Centers for Medicare and Medicaid Services.

Copay Coupons Face Ongoing Pressure • Source: Alamy

The Biden Administration is retaining a Trump-era policy allowing private insurers to prevent the value of manufacturer cost sharing assistance from being counted toward deductibles or out-of-pocket maximums in a recently-issued proposed rule governing health care plans.

The decision not to revise or rescind the policy in the Centers for Medicare and Medicaid Services proposed rule on...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet